drugset
drugset / Trial / NCT02174822

A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects

NCT02174822 ↗

Phase 1 Completed 56 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc.
Non-randomizedParallel-groupOpen-labelOther

Summary

To assess steady state pharmacokinetics (PK), safety and tolerability between AVP-786 (deuterated \[d6\] dextromethorphan hydrobromide \[DM\]/quinidine sulfate \[Q\]) and paroxetine and between AVP-786 and duloxetine.

Timeline

Start
2014-01
Primary completion
2014-03
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AVP-786 Unknown — Oral
Subject Duloxetine Small molecule — Oral
Subject Paroxetine Small molecule — Oral

Indications

No indication recorded.